| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | | |
Result : Searchterm 'T1 Weighted Image' found in 1 term [] and 17 definitions [], (+ 14 Boolean[] results
| 1 - 5 (of 32) nextResult Pages : [1] [2 3 4] [5 6 7] | | | | Searchterm 'T1 Weighted Image' was also found in the following services: | | | | |
| | |
T1 Weighted Image | |
| |
|
| | | | | | | • Share the entry 'T1 Weighted Image': | | | | | | | | Further Reading: | | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
The T1 relaxation time (also called spin lattice or longitudinal relaxation time), is a biological parameter that is used in MRIs to distinguish between tissue types. This tissue-specific time constant for protons, is a measure of the time taken to realign with the external magnetic field. The T1 constant will indicate how quickly the spinning nuclei will emit their absorbed RF into the surrounding tissue.
As the high-energy nuclei relax and realign, they emit energy which is recorded to provide information about their environment. The realignment with the magnetic field is termed longitudinal relaxation and the time in milliseconds required for a certain percentage of the tissue nuclei to realign is termed 'Time 1' or T1. Starting from zero magnetization in the z direction, the z magnetization will grow after excitation from zero to a value of about 63% of its final value in a time of T1. This is the basic of T1 weighted images.
The T1 time is a contrast determining tissue parameter. Due to the slow molecular motion of fat nuclei, longitudinal relaxation occurs rather rapidly and longitudinal magnetization is regained quickly. The net magnetic vector realigns with B0 leading to a short T1 time for fat.
Water is not as efficient as fat in T1 recovery due to the high mobility of the water molecules. Water nuclei do not give up their energy to the lattice (surrounding tissue) as quickly as fat, and therefore take longer to regain longitudinal magnetization, resulting in a long T1 time.
See also T1 Weighted Image, T1 Relaxation, T2 Weighted Image, and Magnetic Resonance Imaging MRI. | | | | | | • View the DATABASE results for 'T1 Time' (15).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | | | | | Searchterm 'T1 Weighted Image' was also found in the following services: | | | | |
| | |
| |
|
Contrast is the relative difference of signal intensities in two adjacent regions of an image.
Due to the T1 and T2 relaxation properties in magnetic resonance imaging, differentiation between various tissues in the body is possible. Tissue contrast is affected by not only the T1 and T2 values of specific tissues, but also the differences in the magnetic field strength, temperature changes, and many other factors. Good tissue contrast relies on optimal selection of appropriate pulse sequences ( spin echo, inversion recovery, gradient echo, turbo sequences and slice profile).
Important pulse sequence parameters are TR ( repetition time), TE (time to echo or echo time), TI (time for inversion or inversion time) and flip angle. They are associated with such parameters as proton density and T1 or T2 relaxation times. The values of these parameters are influenced differently by different tissues and by healthy and diseased sections of the same tissue.
For the T1 weighting it is important to select a correct TR or TI. T2 weighted images depend on a correct choice of the TE. Tissues vary in their T1 and T2 times, which are manipulated in MRI by selection of TR, TI, and TE, respectively. Flip angles mainly affect the strength of the signal measured, but also affect the TR/TI/TE parameters.
Conditions necessary to produce different weighted images:
T1 Weighted Image: TR value equal or less than the tissue specific T1 time - TE value less than the tissue specific T2 time.
T2 Weighted Image: TR value much greater than the tissue specific T1 time - TE value greater or equal than the tissue specific T2 time.
Proton Density Weighted Image: TR value much greater than the tissue specific T1 time - TE value less than the tissue specific T2 time.
See also Image Contrast Characteristics, Contrast Reversal, Contrast Resolution, and Contrast to Noise Ratio. | | | | | | • View the DATABASE results for 'Contrast' (373).
| | | • View the NEWS results for 'Contrast' (77).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
| |
| | | | | |
| |
|
Contrast agents are chemical substances introduced to the anatomical or functional region being imaged, to increase the differences between different tissues or between normal and abnormal tissue, by altering the relaxation times. MRI contrast agents are classified by the different changes in relaxation times after their injection.
•
Negative contrast agents (appearing predominantly dark on MRI) are small particulate aggregates often termed superparamagnetic iron oxide ( SPIO). These agents produce predominantly spin spin relaxation effects (local field inhomogeneities), which results in shorter T1 and T2 relaxation times.
SPIO's and ultrasmall superparamagnetic iron oxides ( USPIO) usually consist of a crystalline iron oxide core containing thousands of iron atoms and a shell of polymer, dextran, polyethyleneglycol, and produce very high T2 relaxivities. USPIOs smaller than 300 nm cause a substantial T1 relaxation. T2 weighted effects are predominant.
•
A special group of negative contrast agents (appearing dark on MRI) are perfluorocarbons ( perfluorochemicals), because their presence excludes the hydrogen atoms responsible for the signal in MR imaging.
The design objectives for the next generation of MR contrast agents will likely focus on prolonging intravascular retention, improving tissue targeting, and accessing new contrast mechanisms. Macromolecular paramagnetic contrast agents are being tested worldwide. Preclinical data shows that these agents demonstrate great promise for improving the quality of MR angiography, and in quantificating capillary permeability and myocardial perfusion.
Ultrasmall superparamagnetic iron oxide ( USPIO) particles have been evaluated in multicenter clinical trials for lymph node MR imaging and MR angiography, with the clinical impact under discussion. In addition, a wide variety of vector and carrier molecules, including antibodies, peptides, proteins, polysaccharides, liposomes, and cells have been developed to deliver magnetic labels to specific sites. Technical advances in MR imaging will further increase the efficacy and necessity of tissue-specific MRI contrast agents.
See also Adverse Reaction and Nephrogenic Systemic Fibrosis.
See also the related poll result: ' The development of contrast agents in MRI is' | | | | | | | | | | | • View the DATABASE results for 'Contrast Agents' (122).
| | | • View the NEWS results for 'Contrast Agents' (25).
| | | | Further Reading: | Basics:
|
|
News & More:
| |
Brain imaging method may aid mild traumatic brain injury diagnosis Tuesday, 16 January 2024 by parkinsonsnewstoday.com | | |
A Targeted Multi-Crystalline Manganese Oxide as a Tumor-Selective Nano-Sized MRI Contrast Agent for Early and Accurate Diagnosis of Tumors Thursday, 18 January 2024 by www.dovepress.com | | |
FDA Approves Gadopiclenol for Contrast-Enhanced Magnetic Resonance Imaging Tuesday, 27 September 2022 by www.pharmacytimes.com | | |
How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol Saturday, 5 February 2022 by www.ncbi.nlm.nih.gov | | |
Estimation of Contrast Agent Concentration in DCE-MRI Using 2 Flip Angles Tuesday, 11 January 2022 by pubmed.ncbi.nlm.nih.gov | | |
Manganese enhanced MRI provides more accurate details of heart function after a heart attack Tuesday, 11 May 2021 by www.news-medical.net | | |
Gadopiclenol: positive results for Phase III clinical trials Monday, 29 March 2021 by www.pharmiweb.co | | |
Gadolinium-Based Contrast Agents Hypersensitivity: A Case Series Friday, 4 December 2020 by www.dovepress.com | | |
Polysaccharide-Core Contrast Agent as Gadolinium Alternative for Vascular MR Monday, 8 March 2021 by www.diagnosticimaging.com | | |
Water-based non-toxic MRI contrast agents Monday, 11 May 2020 by chemistrycommunity.nature.com | | |
New method to detect early-stage cancer identified by Georgia State, Emory research team Friday, 7 February 2020 by www.eurekalert.org | | |
Researchers Brighten Path for Creating New Type of MRI Contrast Agent Friday, 7 February 2020 by www.newswise.com | | |
Manganese-based MRI contrast agent may be safer alternative to gadolinium-based agents Wednesday, 15 November 2017 by www.eurekalert.org | | |
Sodium MRI May Show Biomarker for Migraine Friday, 1 December 2017 by psychcentral.com | | |
A natural boost for MRI scans Monday, 21 October 2013 by www.eurekalert.org | | |
For MRI, time is of the essence A new generation of contrast agents could make for faster and more accurate imaging Tuesday, 28 June 2011 by scienceline.org |
|
| |
| | | | |
| | 1 - 5 (of 32) nextResult Pages : [1] [2 3 4] [5 6 7] |
| |
|
| |
| Look Ups |
| |